A professional cannabis laboratory worker examining a cannabis flower in a petri dish for cannabinoid testing.

THC Compliance: The Importance of Cannabinoid Testing

THC compliance stands out as the main concern for hemp farmers in today’s world when it comes to hemp genetics. High CBD yields are essential but keeping a compliant crop that will not run the risk of destruction due to THC content is the most crucial consideration for a farmer. Today we’ll briefly look at cannabinoids, compliance, testing methods, and the importance of having a testing plan with reliable testing partners before you plant.

The U.S. Farm Bill defines hemp as cannabis that contains less than 0.3% total THC by dry weight. THC, CBD’s psychoactive constituent, is classified as a Schedule 1 drug by the Food and Drug Administration and is highly regulated. CBD is non-psychoactive and is not considered a Schedule 1 drug by the FDA and is not regulated (although recent CBD patents by GW Pharma will incur regulation). Interestingly, many modern CBD-rich hemp genetics derive from so-called “drug-type” cannabis strains that once contained high levels of THC. These genetics were bred over generations to minimize THC production and maximize CBD content.

The truth is that many CBD-rich hemp varietals are nearly indistinguishable from their THC-containing “marijuana” sisters. The visual appeal, aroma (terpene content), and structure can be almost identical between two different genotypes, one with THC and one that does not. When I first started breeding with high CBD/low THC genetics in 2011, it was next to impossible to tell the difference in cannabinoid content until we submitted samples to the lab for cannabinoid testing.

I assumed many of the plants would have high THC content that contained very low THC and had high amounts of CBD. Testing laboratories across the U.S. have opened their doors to hemp growers. Now that hemp is legal in all 50 states, farmers can mail their samples to labs in other States if they cannot find a viable alternative locally.

Colorado has several licensed labs that will accept samples mailed from anywhere in the U.S. It is also essential to understand your State’s requirements for THC testing. Some States test for “total THC”, which is Delta9 THC combined with converted THCA, and others test for only Delta9 THC. Also, understanding the testing method used by your State can help determine a testing partner. In Colorado, the Department of Agriculture uses Gas Chromatography (GC) to determine cannabinoid content. As a result, Foundation Seeds performs GC testing in-house and utilizes High-Performance Liquid Chromatography (HPLC) and Ultra Performance Liquid Chromatography (UPLC) via 3rd party laboratories for confirmation and verification of our in-house results.

What does this mean for you as a CBD hemp farmer? It means you can’t always tell a book by its cover. This makes 3rd party analytical testing paramount to ensuring a successful and compliant crop. We recommend that farmers begin cannabinoid testing once the plants have started flowering every 5-7 days throughout the flowering cycle until harvest. Advanced testing can save you money in avoiding non-compliant crop losses and provide you with valuable crop data to help make informed decisions for the next crop and offer it to a potential buyer or processing partners and commodity traders.

We test all our genetics before releasing and provide our customers with detailed CBD, CBG, and THC cannabinoid maturation curves to understand harvest timelines and cannabinoid content. Our founders bred and have been working with the leading hemp genetics on the market and producing feminized cannabis seeds since 2012.

Eric is the Director of Breeding and Genetics at Catalyst BC.  Article originally posted on the Fondation Seeds website.

Additional Resources

Consulting Services For Cannabis, Hemp, Psilocybin, and Natural Medicine

Testimonials and Public Relations

Latest Articles

  • Cannabis HVAC Design: The Psychrometrics of Profit and Operational Scalability in 2026
    In 2026, the global cannabis market has moved into a “Pharma-Grade” era. As of 2026, the leading cultivators are no longer just managing “temperature and humidity.” They are managing Vapor Pressure Deficit (VPD) and Biogenic Volatile Organic Compounds (BVOCs) to maximize secondary metabolite production (terpenes and cannabinoids) while slashing carbon footprints.
  • The 2026 Strategic Play: Mastering the New York Adult-Use Processor Type 3 Branding License
    In 2021, New York legalized. In 2025, it launched. In April 2026, the market is maturing at an unprecedented rate. The “green rush” of speculative applications has been replaced by a sophisticated “Branding Phase.” As of this month, the Office of Cannabis Management (OCM) has authorized over 532 processors, many of whom are actively seeking high-quality brand partners to fill their white-label capacity.
  • Don’t Get Left Behind: Securing Your New York Cannabis License in 2026
    The era of “provisional waiting” is over. The Office of Cannabis Management (OCM) has now issued over 2,160 adult-use licenses statewide. For entrepreneurs, the message is clear: the market is live, the supply chain is scaling, and the opportunity for professional, compliant operators has never been greater.
  • Overcoming the Complexities of Minnesota Cannabis Licensing in 2026: Navigating the Scale-Up Phase
    In 2026, Minnesota’s cannabis market has transitioned from initial launch to a high-stakes scale-up phase. To succeed, applicants must move beyond basic requirements to demonstrate “pharma-grade” compliance, long-term financial stability, and total operational readiness. We have outlined the most critical hurdles currently facing 2026 applicants – from navigating the 65% social equity ownership audit to overcoming the statewide testing bottleneck.
  • Cannabis Consumption Lounges: Which States Permit On-Site Use in 2026?
    Across much of the U.S., legally consuming cannabis remains largely restricted to private residences – and even then, landlords or HOAs frequently ban it. While retail sales are now legal in the majority of the country, a growing number of jurisdictions are finally moving beyond the “buy-it-and-go” model, authorizing public venues where adults can consume their purchases on-site in a social, regulated setting.
  • Virginia Cannabis Licensing & Business Opportunities (Updated April 2026)
    As Virginia transitions from its current “possession-only” model toward a fully regulated retail market, the 2026–2027 biennium represents a once-in-a-generation window for market entry. Unlike the vertically integrated “medical-only” regimes of the past, Virginia’s upcoming framework focuses on decentralization, specifically architected to favor small Virginia-based operators over large multi-state corporations.

Explore Our Articles

cannabis applications Cannabis Bar Cannabis Business Optmization cannabis careers Cannabis Compliance Cannabis Consumption Cannabis Consumption Bar Cannabis Inventory Management Systems Cannabis Investors cannabis jobs Cannabis Legalization cannabis licensing Cannabis Lounge cannabis marketing Cannabis Operational Procedures cannabis outreach Cannabis Regulations Cannabis Security Cannabis Software Cannabis Startup Cannabis Supply Chain Cannabis Technology Colorado controlled environment agriculture Cultivation cultivation facility Dispensary Design facility design Financial Planning HVAC HVACD Iowa Kansas Legal Update Legislation Medical Cannabis Minnesota Natural Medicine Nebraska New York Odor Control Oregon Psilocybin Psychedelics Recreational Cannabis

Scroll to Top